Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)
China flag China · Delayed Price · Currency is CNY
13.00
-0.39 (-2.91%)
Nov 13, 2026, 3:04 PM CST

SHE:002907 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
93.8365.0976.7332.798.491.78
Depreciation & Amortization
86.2786.2786.9482.1174.6969.84
Other Amortization
5.15.12.451.281.10.57
Loss (Gain) From Sale of Assets
-10.25-10.25--0.06--
Asset Writedown & Restructuring Costs
0.440.440.031.874.770.15
Loss (Gain) From Sale of Investments
-9.69-9.69-1.384.672.611.33
Provision & Write-off of Bad Debts
0.20.21.41---
Other Operating Activities
15.79-12.42-1.220.9514.4218.22
Change in Accounts Receivable
-79.84-79.84-30.384.86-85.87-16.39
Change in Inventory
1.411.4110.59-38.0211.42-8.71
Change in Accounts Payable
18.6718.6717.2845.63-106.82-75.39
Operating Cash Flow
119.262.24161.77219.3413.0482.85
Operating Cash Flow Growth
49.60%-61.52%-26.25%1581.42%-84.25%-27.09%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-35.73-14.56-16.15-92.82-60.62-56.64
Sale of Property, Plant & Equipment
0.066.560---
Cash Acquisitions
4.865.31----
Divestitures
-----0
Investment in Securities
3.37-195.72-94.94-65.0152.04-53
Other Investing Activities
-5.76-6.213.870.493.291.1
Investing Cash Flow
-33.2-204.62-107.21-157.34-5.29-108.54

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
---70--
Long-Term Debt Issued
---0.2--
Total Debt Issued
---70.2--
Short-Term Debt Repaid
----70--12
Long-Term Debt Repaid
--0.16-0.14-0.26-2.19-0.03
Lease Payments
-0.16-0.16-0.14-0.22-0.15-0.03
Total Debt Repaid
-0.16-0.16-0.14-70.26-2.19-12.03
Net Debt Issued (Repaid)
-0.16-0.16-0.14-0.06-2.19-12.03
Repurchase of Common Stock
-----7.11-0.23
Common Dividends Paid
-31.32-35.5-35.5-30.17-23.04-13.4
Other Financing Activities
-13.58-4.09----
Financing Cash Flow
-45.06-39.74-35.63-30.23-32.35-25.66

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.09-0.10.060.070.35-0.09
Net Cash Flow
40.85-182.2118.9931.84-24.24-51.44

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
83.4747.68145.62126.52-47.5726.21
Free Cash Flow Growth
24.50%-67.25%15.09%---60.85%
Free Cash Flow Margin
9.82%5.76%18.79%18.30%-6.06%3.10%
Free Cash Flow Per Share
0.200.110.350.30-0.120.07
Levered Free Cash Flow
28.2182.48117.9631.021.63-2.62
Unlevered Free Cash Flow
30.1982.57117.9631.6110.648.77
Free Cash Flow After Leases
83.3147.52145.48126.3-47.7326.18

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Interest Paid
0.90.9----
Cash Income Tax Paid
98.3103.6980.8280.7660.6889.24
Change in Working Capital
-62.5-62.5-3.295.83-182.95-99.04